Alexandria Real Estate Equities received a consensus 12-month price target of $65.33 from 17 analysts, with ratings mostly holding. The company recently reported quarterly earnings slightly above estimates but saw a revenue decline year-over-year. Chairman Joel S. Marcus increased his stake by 4.65%, signaling insider confidence. Alexandria also announced a $0.72 per share quarterly dividend and a $500 million share buyback program, reflecting management's positive outlook despite mixed analyst views.
Alexandria Real Estate Equities (ARE) is struggling with oversupply and vacancy rates exceeding 30% in key life science markets like Boston, San Francisco, and San Diego. This has caused an 80% decline in its stock price from its peak. The company's ...
A lawsuit has been filed against Alexandria Real Estate Equities, accusing the company of providing false information about leasing spreads, tenant pipeline, and occupancy growth for its Long Island City life-science property. The complaint claims Al...
